Treatment with lysine deacetylase inhibitors (KDACi) for haematological malignancies, is accompanied by haematological side effects including thrombocytopenia, suggesting that modulation of protein ac
Crystal structure of human NatD (NAA40) bound to a bisubstrate analogue with a C-3 linker Descriptor: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ACETYL GROUP, AMINO GROUP, ... A
1:Highest Sieve ratio value found for the respective peptide. 2:biantGal2wFuc: core fucosylated, fully galactosylated complex biantennary glycostructure. 3:for assignment of the corresponding MS/MS sp